Issue Code: PHA
1,751
444
269
2025--2026
LMH STRATEGIC SOLUTIONS
62 activities
MARSHALL & POPP, LLC
49 activities
MEHLMAN CONSULTING, INC.
46 activities
TODD STRATEGY GROUP
HOUSE OF REPRESENTATIVES
1,415 mentionsSENATE
1,400 mentionsHealth & Human Services, Dept of (HHS)
378 mentionsCenters For Medicare and Medicaid Services (CMS)
EXELA PHARMA SCIENCES, LLC
via OLD NORTH STRATEGIES, LLC
on shore medications
ELEVANCE HEALTH, INC.
via ELEVANCE HEALTH, INC.
Drug Patent Reform Pharmacy Benefit Manager (PBM) operations and practices, Spread Pricing, Rebates, Delinking Drug Act (H.R. 2214) Robinson-Patman Act Reform Modernizing and Ensuring PBM Accountability (MEPA) Act (118th Congress) Pharmacy Benefit Manager Transparency Act of 2025 (S. 526) Pharmacy Benefit Manager Reform Act (118th Congress) Patients Before Middlemen Act (S.882) Prescription Drug Transparency and Affordability Act (H.R. 2450) Pharmacists Fight Back Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) One Big Beautiful Bill Act (H.R. 1) Consolidated Appropriations Act of 2026 (H.R.7148)
8 activities
41 activities
B HALL STRATEGIES, LLC
39 activities
RUBICON ADVISORS, LLC
37 activities
BALLARD PARTNERS, LLC
34 activities
DLA PIPER LLP (US)
32 activities
BGR GOVERNMENT AFFAIRS
29 activities
BUCHANAN INGERSOLL & ROONEY PC
28 activities
Food & Drug Administration (FDA)
179 mentionsWhite House Office
151 mentionsExecutive Office of the President (EOP)
106 mentionsOffice of Management & Budget (OMB)
36 mentionsHealth Resources & Services Administration (HRSA)
36 mentionsCommerce, Dept of (DOC)
30 mentionsBAYCARE HEALTH SYSTEM
via BAYCARE HEALTH SYSTEM
Advocated for protection of the existing 340B drug pricing program and concerns around a rebate model at HRSA + general preservation of the 340B drug pricing program. Also discussed the concern around exclusion of the waiver days (low income pool days in Florida).
HENRY MEDS
via RUBICON ADVISORS, LLC
Telehealth Compounding, Regulatory Intelligence
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS
via RUBICON ADVISORS, LLC
Issues related to adult immunization access
ALZHEON
via RUBICON ADVISORS, LLC
Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION
via RUBICON ADVISORS, LLC
Orphan drugs
ASCENDIS PHARMA, INC.
via RUBICON ADVISORS, LLC
Food and Drug Administration, Orphan Drugs
DR. REDDY'S LABORATORIES, LTD
via RUBICON ADVISORS, LLC
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
DYNAVAX TECHNOLOGIES
via RUBICON ADVISORS, LLC
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)